Swiss companies spend millions lobbying US government
Swiss pharmaceutical companies have spent millions of dollars in the United States to fight the Affordable Care Act – often referred to as Obamacare.
Swiss financial companies have also lobbied for tax reform.
The revelations are from a US based anti-corruption organization, the Center for Responsive Politics.
They show Swiss firms spent around USD 23m on lobbying the US government.
One of the biggest spenders was Novartis which spent CHF 8m on lobbying – the numbers show the amounts are at the highest for the last 10 years.
Together with Roche, the drug makers fought to repeal Obamacare and Zurich Insurance and Credit Suisse lobbied to weaken financial regulations.